Rpd3p Relocation Mediates a Transcriptional Response to Rapamycin in Yeast  by Humphrey, Emily L et al.
Chemistry & Biology, Vol. 11, 295–299, March, 2004, 2004 Elsevier Science Ltd. All rights reserved. DOI 10.1016/j .chembiol .2004.03.001
Brief CommunicationRpd3p Relocation
Mediates a Transcriptional Response
to Rapamycin in Yeast
repression, is catalyzed by enzymes called histone
deacetylases (HDACs) [15–17]. To examine whether
HDACs are required for the gene repression observed
following treatment with rapamycin, we examined the
transcriptional response to rapamycin in strains individ-
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3 Harvard Biophysics Program ually deleted for each known HDAC: RPD3, SIR2, HDA1,
HOS1, HOS2, and HOS3. Deletion of RPD3, but no otherHarvard University
12 Oxford Street HDAC, blocks gene repression following treatment with
rapamycin (Figure 1). This is consistent with previousCambridge, Massachusetts 02138
4 Department of Pathology studies that have shown that repression of ribosomal
protein-encoding genes following treatment with rapa-Brigham and Women’s Hospital
Boston, Massachusetts 02115 mycin requires RPD3 [3]. We further show that RPD3 is
required for the rapamycin-induced repression of almost
all functional classes of genes (Table 1). We obtained
similar results for a mutant allele of RPD3 lacking de-Summary
acetylase activity (see Figure S1 available online with
this article) [18]. Specifically, the correlation between theTreating yeast cells with rapamycin, a small molecule
that inhibits the TOR proteins, leads to the repression transcription profiles of the catalytically inactive mutant
and the deletion mutant is 77%. Lastly, SIN3, whichof many genes [1, 2]. Consistent with prior studies, we
find that RPD3, which encodes a histone deacetylase encodes an Rpd3p-complex member, is also required
for this gene repression, and the profile of sin3 yeast(HDAC), is required for repression upon rapamycin
treatment. To elucidate the mechanism underlying treated with rapamycin correlates 90% with that of the
rpd3 deletion mutant (Figure S1). These data suggestRPD3-mediated repression, we screened all promot-
ers in yeast for occupancy by Rpd3p before and after that the Sin3p-Rpd3p complex acts downstream of the
TOR proteins to mediate transcriptional repression.treatment with rapamycin. We find that Rpd3p binds
to the promoters of rapamycin-repressible genes only Previous work has suggested that the promoters of
rapamycin-repressible genes are occupied by Rpd3pfollowing treatment. These data conflict with a pre-
viously proposed model suggesting that Rpd3p is con- under steady-state conditions [4]. Furthermore, it has
been shown that the association of Rpd3p with the pro-stitutively bound to rapamycin-repressible genes and
becomes active only after a stimulus such as treat- moters of two rapamycin-repressible genes is unaf-
fected by treatment with the small molecule [3]. Thesement with rapamycin [3–5]. Rather, the comprehensive
analysis presented here strongly supports a model in results have led to a model in which Rpd3p is constitu-
tively associated with the promoters of genes it re-which recruitment of Rpd3p to gene promoters is a
regulated step in the control of gene repression [6]. presses [5]. Transcriptional repression then requires the
activity of Rpd3p to be modulated, such as by posttrans-
lational modification. However, a mechanism that recon-Results and Discussion
ciles this model with the previous result that Rpd3p
represses a set of genes under steady-state conditionsThe TOR proteins regulate fundamental cellular pro-
cesses in yeast such as transcription, translation, pro- would be very complex, requiring Rpd3p to be active
at only a subset of the promoters to which it is boundtein degradation, and differentiation in response to nutri-
ent levels [7, 8]. The small molecule rapamycin, which under steady-state conditions. A simpler mechanism for
how Rpd3p is regulated would be recruitment of theforms a ternary complex with Fpr1p and TOR, has been
a useful tool enabling the discovery and study of the TOR HDAC to the promoters of rapamycin-repressible genes
following treatment with the small molecule. To deter-proteins [8]. Inhibition of the TOR proteins by rapamycin
mine whether the level of Rpd3p binding in gene promot-leads to a transcriptional response reminiscent of nutri-
ers changes following treatment with rapamycin, weent deprivation [1, 2, 9, 10]. The pathways leading to
used chromatin immunoprecipitation (ChIP) to examinegene activation in response to rapamycin are known to
the promoters of all yeast genes for the presence ofinvolve changes in phosphorylation and localization of
Rpd3p under steady-state conditions and followingseveral transcription factors [1, 10–12]. However, the
treatment with the small molecule. In contrast to previ-pathways leading to gene repression are less under-
ous results, we find that Rpd3p binds to the promoters ofstood, and most studies have focused on the repression
rapamycin-repressible genes following treatment withof one subset of repressed genes, those encoding ribo-
rapamycin, but we find no significant Rpd3p binding tosomal proteins [3, 9, 13, 14]. Our genome-wide study
these promoters under steady-state conditions (Figuresallows us to simultaneously examine the regulation of
2A and 2B). We have confirmed our genome-wide resultall genes repressed following treatment with rapamycin.
at several specific promoters, including those previouslyDeacetylation of histones, which correlates with gene
examined, by performing quantitative PCR on our ChIP
samples (Figure 2C). These gene-specific studies and*Correspondence: stuart_schreiber@harvard.edu
5 These authors contributed equally to this work. our genome-wide analysis both suggest that the TOR
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Table 1. All Rapamycin-Repressible Functional Classes of
Genes Require RPD3 for Repression
WT versus rpd3 versus
Category WT rap rpd3 rap rpd3/WT
RNA polymerase I 0.11 0.68 6.16
ribosome biogenesis/rDNA 0.21 0.69 3.34
transcription factor
rRNA processing 0.23 0.76 3.30
RNA polymerase III 0.27 0.79 2.97
mRNA decay 0.38 0.72 1.89
translation initiation factors 0.50 0.81 1.61
tRNA processing 0.57 0.92 1.61
mRNA export 0.61 0.89 1.45
cytoplasmic ribosomal 0.45 0.64 1.43
proteins
purine biosynthesis 0.61 0.82 1.35
Genes were organized by functional category, and the geometric
mean of fold-change for each category repressed at least 1.5-fold
by rapamycin was computed. The ratio of the fold change in the
rpd3 deletion strain to that of the wild-type strain was calculated
for each category.
many stress-responsive genes that we find to be rapa-
mycin repressible [4]. We suspect that this discrepancy
resulted from differences in our ChIP crosslinking condi-
tions. Specifically, Kurdistani et al. crosslink the yeast
by treating them with dimethyl adipimidate (DMA) in
phosphate-buffered saline solution for 45 min before
addition of formaldehyde [4], while we use only formal-
dehyde. It is possible that these conditions could lead
to a stress response that, like treatment with rapamycin,
would cause Rpd3p to be recruited to stress-responsive
promoters. Alternatively, the binding observed by Kur-
distani et al. may reflect low-level occupancy of these
promoters by Rpd3p under steady-state conditions,Figure 1. RPD3 but No Other HDAC Is Required for the Repression
which is greatly augmented following treatment withof Most Rapamycin-Repressible Genes Following Treatment with
Rapamycin rapamycin.
Log-transformed, averaged transcription profile data sets were clus- Our results argue that a major function of Rpd3p in
tered using average linkage with the program Cluster [26]. The re- promoters is to mediate gene repression in response to
sults are displayed with Treeview [26]. Red bars inidicate genes that stresses such as nutrient deprivation, which is mimicked
were transcriptionally induced, and green bars indicate genes that by treatment with rapamycin. By comparing two differ-
were transcriptionally repressed. The data set for each strain com-
ent types of global data sets, transcription profiles andpares yeast treated with vehicle to those treated with rapamycin.
genome-wide binding data, we were able to show that
RPD3 is required for the repression of many genes with
promoters that are bound by Rpd3p following treatmentproteins regulate the association of Rpd3p with the pro-
moters of rapamycin-repressible genes to control gene with rapamycin, suggesting direct regulation of these
genes by Rpd3p. Some genes that are repressed follow-repression. Although genes transcribed by RNA poly-
merase I can have distinct chromatin regulation [19], ing treatment with rapamycin in an RPD3-dependent
manner are not significantly bound by Rpd3p followingour results are consistent with the findings of Tsang et
al. that Rpd3p is recruited to rDNA promoters to control treatment with rapamycin. Additionally, deletion of
RPD3 also blunts the activation of many rapamycin-repression following treatment with rapamycin [6].
These results suggest a new model in which TOR regu- induced genes, but we do not observe significant asso-
ciation of Rpd3p with the promoters of these genes.lates gene activity by controlling the recruitment of
Rpd3p to the promoters of genes (Figure 3). This suggests that these are indirect effects of deletion
of Rpd3p. Alternatively, Rpd3p may associate with theUnder steady-state conditions, we find that Rpd3p
associates with promoters containing the Ume6p bind- promoters of these genes transiently or weakly, such
that our methods cannot detect the association. Thus,ing site (URS1), consistent with the known role for
Ume6p in the recruitment of Rpd3p to repress these we suggest that a critical role of Rpd3p in the TOR
pathway is to mediate gene repression.genes [4, 17, 20, 21]. Specifically, 17 of the 84 promoters
bound by Rpd3p at least 2-fold under steady-state con-
ditions contain URS1 sites (p  6.0  108). This finding Significance
contrasts with another genome-wide study reporting the
association of Rpd3p with additional promoters under We propose a model in which inhibition of the TOR
pathway by rapamycin leads to the recruitment ofsteady-state conditions, including the promoters of
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Figure 2. Treatment with Rapamycin Leads to the Recruitment of Rpd3p to the Promoters of Genes that Become Repressed
(A) Overlaps between genes repressed at least 2-fold following treatment with rapamycin but at least 2-fold less repressed in an rpd3 mutant,
genes bound at least 2-fold by Rpd3p under steady-state conditions, and genes bound at least 2-fold by Rpd3p following treatment with
rapamycin.
(B) The moving average (window size, 50; step size, 1) of log2 fold change in binding of Rpd3p to gene promoters following treatment with
rapamycin plotted against the percentage of corresponding genes that are activated or repressed.
(C) Quantitative PCR amplifying several promoters from Rpd3p ChIP samples from either vehicle- or rapamycin-treated cells. The fold-
enrichment of the indicated promoter in Rpd3p ChIP samples relative to WCE samples is plotted.
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referred to as whole-cell extract (WCE), was reserved and treated
exactly as the immunoprecipitated DNA.
Quantitative PCR
The promoters of selected genes were each amplified from approxi-
mately 1/30 of the immunoprecipitated material using Qiagen SYBR
green PCR mix in an MJ Research real-time PCR machine according
to the manufacturers’ instructions. The following primer pairs were
used for quantitative PCR: RPC25 promoter, 5-TTCGTGCTTTTTA
TATTCCCCTTA-3 and 5-ATAACGCTTCTTGCGTCTATTTCT-3;
RPA43 promoter, 5-GCCCCGTAATAGATGTATTTCAGG-3 and 5-
CCACGTTTGTCTCTTATCTTTCTG-3; RRP3 promoter, 5-AAAGA
AGTTTGACCCACTCTGATT-3 and 5-TCTCATCGCGATATTAGTTCFigure 3. The TOR Signaling Pathway Regulates Gene Repression
GATA-3; RPL8a promoter, 5-GAAAACACCCAAACATATCTAGGC-by Controlling the Recruitment of Rpd3p to Gene Promoters
3 and 5-AGCAATGTAAACTGACAACTGGAA-3; RPL9a promoter,
In the absence of rapamycin, the TOR signaling pathway prevents
5-TGTCCTGCGTATAGAGGAGAAAAA-3 and 5-ATGTTGGAAATT
the recruitment of Rpd3p to the promoters of rapamycin-repressible
TCATCGCTTCTT-3; RPS11b promoter, 5-GAAGAAATATTTCCTT
genes through an unknown mechanism. Inhibition of the TOR path-
GCTGCACC-3 and 5-CTGGCTTGATACGTTTCCTCTAAG-3; TUB2
way with rapamycin leads to the recruitment of Rpd3p to gene
promoter, 5-GGCCTAACAGTAAAGATATCCTCC-3 and 5-GTTG
promoters, likely causing gene repression through local deacetyla-
TAGTAGCTGCTATGTCACTC-3.
tion of histones.
Fold binding of Rpd3p to gene promoters was determined using
the 2-CT method described in the Applied Biosystems User Bulletin
No. 2 (P/N 4303859). For each promoter examined, the promoter of
TUB2 was used as the normalizer, and the WCE sample was usedRpd3p to gene promoters to cause gene repression.
as the calibrator. Each fold binding reported represents the averageThis model is reminiscent of the known role for the
of three independent experiments, each done in duplicate.TOR pathway in regulating the association of Esa1p,
a histone acetyltransferase, with its target promoters
DNA Amplification, Labeling of ChIP Samples,
to cause gene activation [3, 22]. It is consistent with and Hybridizations
a dynamic and central role for chromatin-modifying DNA immunoprecipitated from 90 ml of cells and DNA isolated from
enzymes in mediating the rapid changes in transcrip- approximately half of the reserved WCE were amplified as described
[24]. WCE DNA and immunoprecipitated DNA were fluorescentlytion required for adaptation to nutrient stress. Further-
labeled by incubating them with monofunctional reactive Cy3 andmore, this work demonstrates the utility of combining
Cy5 dyes, respectively, as described [25]. Samples were hybridizedsmall molecule perturbations with genome-wide anal-
to microarrays, and data were analyzed as for transcription profiling
ysis to probe transcriptional regulatory pathways. Fu- experiments. Each data set represents the average of three indepen-
ture work will be directed toward understanding the dent experiments.
mechanism by which the TOR pathway regulates the Complete genome-wide data sets are available at http://www.
schreiber.chem.harvard.edu.recruitment of Rpd3p to gene promoters.
Supplemental DataExperimental Procedures
Supplemental data including a figure, genome-wide transcription
profiling data, and Rpd3p binding data are available at http://www.Yeast Strains
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otherwise isogenic wild-type strain BY4741 were obtained from Re-
Acknowledgmentssearch Genetics. The rpd3 mutant was previously described [23].
The catalytically inactive rpd3 mutant and the myc-tagged RPD3
The authors thank Chih Long Liu and Sirinya Matchacheep for theirstrain were generous gifts from T. Tsukiyama [18] and M. Grunstein
assistance. This work was supported by a grant from the National[4], respectively.
Institute for General Medical Sciences (GM-38627 to S.L.S.). A.F.S.
is supported by a Howard Hughes Medical Institute predoctoral
Transcription Profiling fellowship. B.E.B. is supported by a K08 Development Award from
Transcription profiling experiments were performed as previously the National Cancer Institute. S.L.S. is an Investigator at the Howard
described [23]. Briefly, 100 ml of yeast were grown to OD600  1 Hughes Medical Institute.
in yeast extract/peptone/dextrose and treated with either 50 nM
rapamycin or vehicle control for 30 min. mRNA was purified and Received: January 5, 2004
fluorescently-labeled cDNA probes were generated as previously Revised: February 23, 2004
described [23]. Vehicle-treated sample (Cy3) and rapamycin-treated Accepted: February 24, 2004
sample (Cy5) were competitively hybridized to cDNA microarrays. Published: March 19, 2004
Slides were scanned with an Axon 4000B scanner equipped with
genepix pro software, and all microarray data sets were processed References
according to the Stanford microarray database protocol. Each data
set represents the average of two independent experiments. DNA 1. Hardwick, J.S., Kuruvilla, F.G., Tong, J.K., Shamji, A.F., and
microarrays were constructed as described [23]. Schreiber, S.L. (1999). Rapamycin-modulated transcription de-
fines the subset of nutrient-sensitive signaling pathways directly
controlled by the TOR proteins. Proc. Natl. Acad. Sci. USA 96,ChIP
DNA associated with Rpd3p was immunoprecipitated from 90 ml 14866–14870.
2. Cardenas, M.E., Cutler, N.S., Lorenz, M.C., Di Como, C.J., andof yeast cells containing endogenously myc-tagged RPD3 grown to
an OD600 of 1.0, then treated for 30 min with either 50 nM rapa- Heitman, J. (1999). The TOR signaling cascade regulates gene
expression in response to nutrients. Genes Dev. 13, 3271–3279.mycin or a vehicle control. Cells were crosslinked and lysed as
described [23]. The immunoprecipitation was carried out using 30 3. Rohde, J.R., and Cardenas, M.E. (2003). The tor pathway regu-
lates gene expression by linking nutrient sensing to histoneg of 9E10 anti-myc antibody (Upstate Biotechnology) as described
[23]. Approximately 1/50 of the preimmunoprecipitation material, acetylation. Mol. Cell. Biol. 23, 629–635.
Treatment with Rapamycin Leads to Rpd3p Relocation
299
4. Kurdistani, S.K., Robyr, D., Tavazoie, S., and Grunstein, M. dependent kinase reveals a role in the environmental stress
response. Proc. Natl. Acad. Sci. USA 98, 12578–12583.(2002). Genome-wide binding map of the histone deacetylase
Rpd3 in yeast. Nat. Genet. 31, 248–254. 26. Eisen, M.B., Spellman, P.T., Brown, P.O., and Botstein, D. (1998).
Cluster analysis and display of genome-wide expression pat-5. Rando, O.J., Chi, T.H., and Crabtree, G.R. (2003). Second mes-
senger control of chromatin remodeling. Nat. Struct. Biol. 10, terns. Proc. Natl. Acad. Sci. USA 95, 14863–14868.
81–83.
6. Tsang, C.K., Bertram, P.G., Ai, W., Drenan, R., and Zheng, X.F.
(2003). Chromatin-mediated regulation of nucleolar structure
and RNA Pol I localization by TOR. EMBO J. 22, 6045–6056.
7. Cutler, N.S., Pan, X., Heitman, J., and Cardenas, M.E. (2001).
The TOR signal transduction cascade controls cellular differen-
tiation in response to nutrients. Mol. Biol. Cell 12, 4103–4113.
8. Schmelzle, T., and Hall, M.N. (2000). TOR, a central controller
of cell growth. Cell 103, 253–262.
9. Shamji, A.F., Kuruvilla, F.G., and Schreiber, S.L. (2000). Parti-
tioning the transcriptional program induced by rapamycin
among the effectors of the TOR proteins. Curr. Biol. 10, 1574–
1581.
10. Beck, T., and Hall, M.N. (1999). The TOR signalling pathway
controls nuclear localization of nutrient-regulated transcription
factors. Nature 402, 689–692.
11. Saxena, D., Kannan, K.B., and Brandriss, M.C. (2003). Rapa-
mycin treatment results in GATA factor-independent hyper-
phosphorylation of the proline utilization pathway activator in
Saccharomyces cerevisiae. Eukaryot. Cell 2, 552–559.
12. Komeili, A., Wedaman, K.P., O’Shea, E.K., and Powers, T. (2000).
Mechanism of metabolic control. Target of rapamycin signaling
links nitrogen quality to the activity of the Rtg1 and Rtg3 tran-
scription factors. J. Cell Biol. 151, 863–878.
13. Powers, T., and Walter, P. (1999). Regulation of ribosome bio-
genesis by the rapamycin-sensitive TOR-signaling pathway in
Saccharomyces cerevisiae. Mol. Biol. Cell 10, 987–1000.
14. Duvel, K., Santhanam, A., Garrett, S., Schneper, L., and Broach,
J.R. (2003). Multiple roles of Tap42 in mediating rapamycin-
induced transcriptional changes in yeast. Mol. Cell 11, 1467–
1478.
15. Robyr, D., Suka, Y., Xenarios, I., Kurdistani, S.K., Wang, A.,
Suka, N., and Grunstein, M. (2002). Microarray deacetylation
maps determine genome-wide functions for yeast histone de-
acetylases. Cell 109, 437–446.
16. Kurdistani, S.K., and Grunstein, M. (2003). Histone acetylation
and deacetylation in yeast. Nat. Rev. Mol. Cell Biol. 4, 276–284.
17. Kadosh, D., and Struhl, K. (1997). Repression by Ume6 involves
recruitment of a complex containing Sin3 corepressor and Rpd3
histone deacetylase to target promoters. Cell 89, 365–371.
18. Goldmark, J.P., Fazzio, T.G., Estep, P.W., Church, G.M., and
Tsukiyama, T. (2000). The Isw2 chromatin remodeling complex
represses early meiotic genes upon recruitment by Ume6p. Cell
103, 423–433.
19. Cioci, F., Vu, L., Eliason, K., Oakes, M., Siddiqi, I.N., and Nomura,
M. (2003). Silencing in yeast rDNA chromatin: reciprocal rela-
tionship in gene expression between RNA polymerase I and II.
Mol. Cell 12, 135–145.
20. Bernstein, B.E., Tong, J.K., and Schreiber, S.L. (2000). Ge-
nomewide studies of histone deacetylase function in yeast.
Proc. Natl. Acad. Sci. USA 97, 13708–13713.
21. Rundlett, S.E., Carmen, A.A., Suka, N., Turner, B.M., and
Grunstein, M. (1998). Transcriptional repression by UME6 in-
volves deacetylation of lysine 5 of histone H4 by RPD3. Nature
392, 831–835.
22. Reid, J.L., Iyer, V.R., Brown, P.O., and Struhl, K. (2000). Coordi-
nate regulation of yeast ribosomal protein genes is associated
with targeted recruitment of Esa1 histone acetylase. Mol. Cell
6, 1297–1307.
23. Bernstein, B.E., Humphrey, E.L., Erlich, R.L., Schneider, R., Bou-
man, P., Liu, J.S., Kouzarides, T., and Schreiber, S.L. (2002).
Methylation of histone H3 Lys 4 in coding regions of active
genes. Proc. Natl. Acad. Sci. USA 99, 8695–8700.
24. Liu, C.L., Schreiber, S.L., and Bernstein, B.E. (2003). Develop-
ment and validation of a T7 based linear amplification for geno-
mic DNA. BMC Genomics 4, 19.
25. Carroll, A.S., Bishop, A.C., DeRisi, J.L., Shokat, K.M., and
O’Shea, E.K. (2001). Chemical inhibition of the Pho85 cyclin-
